{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-052148","form_type":"8-K","ticker":"RYAN","cik":"0001849253","company_name":"RYAN SPECIALTY HOLDINGS, INC.","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.787096+00:00","generated_at":"2026-06-03T00:53:37.066550+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ryan Specialty Q1 revenue $552M (+20.6% YoY); adj. EPS $0.35 (+34.6%)","bullets":["Total revenue $552.0M, up 20.6% YoY; organic revenue growth 13.7% vs. 13.4% prior year.","Net income $40.7M, +11.6% YoY; adjusted net income $95.4M, +32.9% YoY.","Adjusted EBITDAC $157.2M, +25.8% YoY; margin expanded 120 bps to 28.5%.","Adjusted diluted EPS $0.35, up 34.6% YoY; regular quarterly dividend of $0.11/share declared.","Completed acquisition of Castel on May 1, 2024, adding international delegated authority capability."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-052148","json":"https://secwatch.observer/filing/0000950170-24-052148.json","markdown":"https://secwatch.observer/filing/0000950170-24-052148.md","text":"https://secwatch.observer/filing/0000950170-24-052148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1849253/000095017024052148/0000950170-24-052148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1849253/000095017024052148/ryan-20240331.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:53:37.066550+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e7cb6398410eaf53fe4dee60771a554a4603e117","claim":"RYAN SPECIALTY HOLDINGS, INC. reported first quarter ended March 31, 2024 results: revenue $552.0 million, net income $40.7 million, EPS $0.13 per diluted share.","evidence_excerpt":"RYAN SPECIALTY REPORTS FIRST QUARTER 2024 RESULTS - Total Revenue grew 20.6% year-over-year to $552.0 million - - Organic Revenue Growth Rate* of 13.7% year-over-year 1 - - Net Income of $40.7 million, or $0.13 per diluted share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1849253/000095017024052148/0000950170-24-052148-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$552.0 million"},{"label":"Net income","value":"$40.7 million"},{"label":"EPS","value":"$0.13 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}